What is WO2000062778 (and how does it relate to dasatinib)?
WO2000062778 is a World Intellectual Property Organization (PCT) publication number. To connect it specifically to dasatinib, you’d typically need to check the publication record (title, assignee/applicant, and abstract/claims) in a patent database such as Google Patents.
However, with only the publication number provided, I can’t confirm what WO2000062778 covers (for example, whether it is dasatinib-specific, related to kinase inhibitors generally, or a different compound entirely). The link between the publication and dasatinib is determined by what the claims and examples actually disclose.
If you paste the Google Patents link you’re looking at (or the title/assignee from the record), I can interpret what it claims and whether it is directly about dasatinib.
How to find the dasatinib connection on Google Patents
On the Google Patents page for WO2000062778, the key fields to look at are:
- Title and abstract: do they name dasatinib or describe the same chemical structure class?
- Applicant/assignee: dasatinib’s key developers are typically tied to specific pharma/chemical assignees.
- Claims: are the claimed compounds tied to the dasatinib scaffold (or clearly to dasatinib’s target profile and structure)?
- Examples and chemical definitions: does the document explicitly list dasatinib or a named equivalent?
Is WO2000062778 likely to be a “dosage/formulation” patent or a “compound” patent?
Most dasatinib-related patent families tend to fall into categories like:
- Compound claims (the molecule itself or closely related analogs)
- Formulation claims (e.g., tablets/suspensions and manufacturing details)
- Method-of-use claims (e.g., treating specific cancers or kinase-driven diseases)
WO numbers by themselves don’t indicate which category it is. The record content (claims/summary) determines that.
Can you share the exact Google Patents page?
Send either:
- the URL to the Google Patents entry, or
- the publication title + applicant/assignee shown on the page
…and I’ll tell you whether WO2000062778 is about dasatinib, what it covers (compound vs. formulation vs. use), and which parts of the claims/abstract establish the link.